Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

EBOS Group's , major shareholder Sybos is selling NZ$949 million ($566.74 million) worth of shares in the New Zealand-based medical equipment manufacturer, according to a term sheet by Reuters.

Everyone said I was an idiot because the big guys would squash us, but we are still here almost three decades on,” Atkinson ...